Muralikrishna Tangirala, MS, MPH

home / authors / muralikrishna-tangirala-ms-mph

Articles

Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast Cancer

October 1st 2011

Compared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777